248 related articles for article (PubMed ID: 27129265)
1. Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.
Jancsó Z; Sahin-Tóth M
J Biol Chem; 2016 Jun; 291(25):12897-905. PubMed ID: 27129265
[TBL] [Abstract][Full Text] [Related]
2. Autoactivation of mouse trypsinogens is regulated by chymotrypsin C via cleavage of the autolysis loop.
Németh BC; Wartmann T; Halangk W; Sahin-Tóth M
J Biol Chem; 2013 Aug; 288(33):24049-62. PubMed ID: 23814066
[TBL] [Abstract][Full Text] [Related]
3. Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants.
Geisz A; Hegyi P; Sahin-Tóth M
FEBS J; 2013 Jun; 280(12):2888-99. PubMed ID: 23601753
[TBL] [Abstract][Full Text] [Related]
4. Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C.
Szabó A; Sahin-Tóth M
J Biol Chem; 2012 Jun; 287(24):20701-10. PubMed ID: 22539344
[TBL] [Abstract][Full Text] [Related]
5. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
6. Mesotrypsin Signature Mutation in a Chymotrypsin C (CTRC) Variant Associated with Chronic Pancreatitis.
Szabó A; Ludwig M; Hegyi E; Szépeová R; Witt H; Sahin-Tóth M
J Biol Chem; 2015 Jul; 290(28):17282-92. PubMed ID: 26013824
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic cellular role of the p.L104P human cationic trypsinogen variant in chronic pancreatitis.
Balázs A; Hegyi P; Sahin-Tóth M
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G477-86. PubMed ID: 26822915
[TBL] [Abstract][Full Text] [Related]
8. Mouse model of PRSS1 p.R122H-related hereditary pancreatitis highlights context-dependent effect of autolysis-site mutation.
Jancsó Z; Morales Granda NC; Demcsák A; Sahin-Tóth M
Pancreatology; 2023 Mar; 23(2):131-142. PubMed ID: 36797199
[TBL] [Abstract][Full Text] [Related]
9. Determinants of chymotrypsin C cleavage specificity in the calcium-binding loop of human cationic trypsinogen.
Szabó A; Sahin-Tóth M
FEBS J; 2012 Dec; 279(23):4283-92. PubMed ID: 23035638
[TBL] [Abstract][Full Text] [Related]
10. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis.
Sahin-Tóth M
J Biol Chem; 2000 Jul; 275(30):22750-5. PubMed ID: 10801865
[TBL] [Abstract][Full Text] [Related]
11. Zymogen activation confers thermodynamic stability on a key peptide bond and protects human cationic trypsin from degradation.
Szabó A; Radisky ES; Sahin-Tóth M
J Biol Chem; 2014 Feb; 289(8):4753-61. PubMed ID: 24403079
[TBL] [Abstract][Full Text] [Related]
12. Trypsinogen stabilization by mutation Arg117-->His: a unifying pathomechanism for hereditary pancreatitis?
Sahin-Tóth M; Gráf L; Tóth M
Biochem Biophys Res Commun; 1999 Oct; 264(2):505-8. PubMed ID: 10529393
[TBL] [Abstract][Full Text] [Related]
13. Functional effects of 13 rare PRSS1 variants presumed to cause chronic pancreatitis.
Schnúr A; Beer S; Witt H; Hegyi P; Sahin-Tóth M
Gut; 2014 Feb; 63(2):337-43. PubMed ID: 23455445
[TBL] [Abstract][Full Text] [Related]
14. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis.
Witt H; Sahin-Tóth M; Landt O; Chen JM; Kähne T; Drenth JP; Kukor Z; Szepessy E; Halangk W; Dahm S; Rohde K; Schulz HU; Le Maréchal C; Akar N; Ammann RW; Truninger K; Bargetzi M; Bhatia E; Castellani C; Cavestro GM; Cerny M; Destro-Bisol G; Spedini G; Eiberg H; Jansen JB; Koudova M; Rausova E; Macek M; Malats N; Real FX; Menzel HJ; Moral P; Galavotti R; Pignatti PF; Rickards O; Spicak J; Zarnescu NO; Böck W; Gress TM; Friess H; Ockenga J; Schmidt H; Pfützer R; Löhr M; Simon P; Weiss FU; Lerch MM; Teich N; Keim V; Berg T; Wiedenmann B; Luck W; Groneberg DA; Becker M; Keil T; Kage A; Bernardova J; Braun M; Güldner C; Halangk J; Rosendahl J; Witt U; Treiber M; Nickel R; Férec C
Nat Genet; 2006 Jun; 38(6):668-73. PubMed ID: 16699518
[TBL] [Abstract][Full Text] [Related]
15. Novel Pathogenic
Jancsó Z; Oracz G; Kujko AA; Kolodziejczyk E; Radisky ES; Rygiel AM; Sahin-Tóth M
Front Genet; 2019; 10():46. PubMed ID: 30792736
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathology and evolutionary and physiological implications of pancreatitis-associated cationic trypsinogen mutations.
Chen JM; Montier T; Férec C
Hum Genet; 2001 Sep; 109(3):245-52. PubMed ID: 11702203
[TBL] [Abstract][Full Text] [Related]
17. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y.
Szmola R; Sahin-Tóth M
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11227-32. PubMed ID: 17592142
[TBL] [Abstract][Full Text] [Related]
18. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --> Cys) that alters autoactivation and autodegradation of cationic trypsinogen.
Simon P; Weiss FU; Sahin-Toth M; Parry M; Nayler O; Lenfers B; Schnekenburger J; Mayerle J; Domschke W; Lerch MM
J Biol Chem; 2002 Feb; 277(7):5404-10. PubMed ID: 11719509
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation.
Toldi V; Szabó A; Sahin-Tóth M
J Biol Chem; 2020 Mar; 295(11):3447-3455. PubMed ID: 32014997
[TBL] [Abstract][Full Text] [Related]
20. Hereditary pancreatitis-associated mutation asn(21) --> ile stabilizes rat trypsinogen in vitro.
Sahin-Tóth M
J Biol Chem; 1999 Oct; 274(42):29699-704. PubMed ID: 10514442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
